EDIT vs NDSN · rev $32.3M vs P/E 31, rev $2.69B
Editas Medicine Inc (EDIT) versus Nordson Corporation (NDSN) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Nordson Corporation (NDSN) is a specialty industrial machinery company listed on NASDAQ.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported NDSN revenue for 2024-10-31 was $2.69B. Net income was $467.3M. Revenue was up 2.3% from 2023-10-31 to 2024-10-31. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
EDIT currently screens at market cap $375.2M. NDSN currently screens at market cap $16.17B and trailing P/E 31.0.
Not investment advice. Open the EDIT and NDSN stock pages for the full models.
Not investment advice.